Fifth Third Bancorp Increases Stake in U.S. Physical Therapy, Inc. $USPH

Posted by Brenda Bartman on Jul 28th, 2026

Fifth Third Bancorp lifted its holdings in shares of U.S. Physical Therapy, Inc. (NYSE:USPH – Free Report) by 2,540.5% during the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 10,298 shares of the company’s stock after purchasing an additional 9,908 shares during the period. Fifth Third Bancorp’s holdings in U.S. Physical Therapy were worth $772,000 as of its most recent filing with the SEC.

A number of other large investors also recently added to or reduced their stakes in the business. Hantz Financial Services Inc. lifted its stake in U.S. Physical Therapy by 56.4% in the fourth quarter. Hantz Financial Services Inc. now owns 366 shares of the company’s stock worth $29,000 after purchasing an additional 132 shares during the last quarter. Advisory Services Network LLC bought a new position in shares of U.S. Physical Therapy during the third quarter valued at about $39,000. GAMMA Investing LLC increased its holdings in shares of U.S. Physical Therapy by 207.1% in the fourth quarter. GAMMA Investing LLC now owns 516 shares of the company’s stock worth $40,000 after buying an additional 348 shares during the period. iSAM Funds UK Ltd purchased a new position in shares of U.S. Physical Therapy in the third quarter worth about $52,000. Finally, Blue Trust Inc. lifted its stake in shares of U.S. Physical Therapy by 36.4% in the 4th quarter. Blue Trust Inc. now owns 873 shares of the company’s stock valued at $68,000 after acquiring an additional 233 shares during the last quarter.

U.S. Physical Therapy Stock Performance

Shares of NYSE:USPH opened at $75.96 on Tuesday. The company has a market cap of $1.16 billion, a price-to-earnings ratio of 151.93, a price-to-earnings-growth ratio of 2.06 and a beta of 1.15. The company has a 50-day moving average price of $67.36 and a 200-day moving average price of $74.53. The company has a current ratio of 1.19, a quick ratio of 1.19 and a debt-to-equity ratio of 0.41. U.S. Physical Therapy, Inc. has a 12 month low of $58.19 and a 12 month high of $93.50.

U.S. Physical Therapy (NYSE:USPH – Get Free Report) last posted its earnings results on Wednesday, May 6th. The company reported $0.46 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.55 by ($0.09). The business had revenue of $198.29 million during the quarter, compared to the consensus estimate of $200.94 million. U.S. Physical Therapy had a return on equity of 8.81% and a net margin of 4.36%.The firm’s revenue for the quarter was up 7.9% compared to the same quarter last year. During the same period in the previous year, the business earned $0.48 earnings per share. As a group, equities analysts anticipate that U.S. Physical Therapy, Inc. will post 2.99 EPS for the current year.

U.S. Physical Therapy Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, June 12th. Shareholders of record on Friday, May 22nd were issued a $0.46 dividend. The ex-dividend date was Friday, May 22nd. This represents a $1.84 annualized dividend and a yield of 2.4%. U.S. Physical Therapy’s dividend payout ratio (DPR) is 368.00%.

Analyst Upgrades and Downgrades

USPH has been the subject of several analyst reports. Citizens Jmp restated a “market outperform” rating and set a $98.00 target price on shares of U.S. Physical Therapy in a report on Wednesday, June 24th. Citigroup reaffirmed a “market outperform” rating on shares of U.S. Physical Therapy in a research note on Friday. Barrington Research dropped their price objective on U.S. Physical Therapy from $103.00 to $90.00 and set an “outperform” rating for the company in a research note on Wednesday, May 13th. Zacks Research raised U.S. Physical Therapy from a “strong sell” rating to a “hold” rating in a research note on Wednesday, May 27th. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of U.S. Physical Therapy in a report on Friday, May 29th. One analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $97.50.

Check Out Our Latest Research Report on USPH

Insiders Place Their Bets

In other U.S. Physical Therapy news, Director Peter Francis Minan acquired 492 shares of the business’s stock in a transaction dated Monday, June 8th. The shares were purchased at an average cost of $63.14 per share, for a total transaction of $31,064.88. Following the transaction, the director owned 2,923 shares in the company, valued at $184,558.22. This represents a 20.24% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 2.40% of the company’s stock.

U.S. Physical Therapy Profile

(Free Report)

U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.